Synthetic Studies Towards Fluconazole Analogues

Total Page:16

File Type:pdf, Size:1020Kb

Synthetic Studies Towards Fluconazole Analogues SYNTHETIC STUDIES TOWARDS FLUCONAZOLE ANALOGUES BY SULEMAN RIYAJSAHEB MAUJAN DR. H. B. BORATE (RESEARCH GUIDE) ORGANIC CHEMISTRY DIVISION NATIONAL CHEMICAL LABORATORY DR. HOMI BHABHA ROAD PUNE–411008 (India) MAY–2010 SYNTHETIC STUDIES TOWARDS FLUCONAZOLE ANALOGUES A THESIS SUBMITTED FOR THE DEGREE OF DOCTOR OF PHILOSOPHY (IN CHEMISTRY) TO UNIVERSITY OF PUNE BY Mr. SULEMAN RIYAJSAHEB MAUJAN Dr. H. B. BORATE (RESEARCH GUIDE) ORGANIC CHEMISTRY DIVISION NATIONAL CHEMICAL LABORATORY DR. HOMI BHABHA ROAD PUNE–411008 MAY–2010 Dr. H. B. Borate Telephone: +91-20-25902546 Sc. F Telefax : +91-20-25902629 Division of Organic Chemistry E mail: [email protected] CERTIFICATE This is to certify that the work presented in this thesis entitled “SYNTHETIC STUDIES TOWARDS FLUCONAZOLE ANALOGUES” submitted by Mr. Suleman R. Maujan, has been carried out by the candidate at National Chemical Laboratory, Pune, India, under my supervision. Such materials as obtained from other sources have been duly acknowledged in the thesis. This work is original and has not been submitted for any other degree or diploma of this or any other university. MAY 2010 Dr. H. B. BORATE CANDIDATE’S DECLARATION I hereby declare that the research work presented in the thesis entitled “SYNTHETIC STUDIES TOWARDS FLUCONAZOLE ANALOGUES” was carried out by me at the National Chemical Laboratory, Pune, India, under the supervision of Dr. H. B. BORATE, Sc. F, Division of Organic Chemistry, National Chemical Laboratory, Pune, India and submitted for the degree of Doctor of Philosophy in Chemistry to the University of Pune. This work is original and has not been submitted in part or full by me for any other degree or diploma of this or any other university. MAY 2010 SULEMAN R. MAUJAN Acknowledgements It gives me a great pleasure to express my deep sense of gratitude to my mentor and guide Dr. H. B. Borate for his constant and generous support and guidance. I am grateful to him for giving me a great opportunity to develop my potential to contribute in organic chemistry and motivating me to carry out research in medicinal chemistry. I am fortunate enough to have Dr. (Mrs.) R. D. Wakharkar in achieving this entire endeavor. I am grateful to her for her help in my initial period at NCL. I am very much grateful to Dr. S. P. Chavan, Dr. U. R. Kalkote and Dr. A. G. Gaikwad for their advice, guidance, support and encouragement during every stage of this research work. Discussion with them was really a great pleasure and fetched me a lot of learning experience. I take this opportunity to thank staff at microbial testing laboratory of FDC Ltd., Mumbai for screening of biological activity of new molecules. Without their help, it would have been an incomplete research. My thanks are due to Dr. M. K. Gurjar, (former Head, OCT Division) for his constant support. It is my privilege to thank Dr. G. Pandey, Head, OCD and Dr. S. Sivaram (Director, NCL) for permitting me to work in NCL. I sincerely thank CSIR, New Delhi, for the Fellowship. I am also grateful to Dr. M. N. Deshmukh, Dr. J. M. Gajbhiye, Dr. D. D. Sawaikar, Dr. R. G. Kelkar, Dr. S. R. Bhide, Dr. (Mrs.) V. S. Pore and Dr. (Mrs.) B. Chanda for their help and encouragement. I would also like to acknowledge all the staff members of GC, HPLC, IR, NMR, Mass, Microanalysis, X-ray analysis, Library, Administration and Technical divisions of NCL for their valuable assistance. I wish to express a great sense of gratitude for Prof. B. P. Bandgar (Vice-Chancellor, University of Solapur, former HOD, School of Chemical Sciences, SRTM University, Nanded) for his inspirational teaching. Also I thank my teachers, Prof. P. K. Zubaidha, Dr. Kamble, Dr. Karde, Dr. Tale, Dr. (Mrs.) Makone, S. R. T. M. University (Campus) Nanded, during my M. Sc. Studies and Dr. Salunke, Dr. Birajdar, Dr. Chandrawanshi, Mr. Dhawale, Mr. Sanap, Mr. Palkhe and Mrs. Gore (Shahu College, Latur) during my B. Sc. Studies, for their encouragement and motivation. It is my great pleasure to thank my beloved friends Abasaheb and Manmath for their continuous encouragement, discussion and advice and with whom I shared golden moments. I would like to extend my thanks to Omprakash, Jaman, Kotalwar, Dandge and Narladkar for making my stay in Pune comfortable and memorable. Most importantly, I am very much thankful to my labmates Vishal, Shinde, Vinod, Mrs. Vasudha, Navnath, Vilas, Milind, Mrs. Deepa, Mrs. Shubhada, Lahore, Bhole and Amit for helping me in various capacities throughout my work and maintaining cheerful atmosphere in the lab. Thanks are also due to Santosh, Vaibhav, Talha, Maqsood, Pravin, Sandeep, Ravi, Suresh, Lakshman, Suleman, Jamil, Sachin, Seema, Pradnya, Ashfaq, Mahesh, Dhiraj, Pratap, Prem, Jayant, Gopi, Rohit and Sanil for maintaining cheerful atmosphere in our laboratory. I take this opportunity to thank my present labmates Sangamesh, Shankar, Pankaj, Ananda, Jaydeep, Mrs. Manisha and Sandip. They made working in the lab enjoyable and memorable. No words will be sufficient to express my thanks to my friends Shriram, Amol, Nagendra, Kulbhushan, Namdev, Sharad, Nilkanth, Pandurang, Awadhut, Ganesh, Abhijit, Sudhir, Taterao, Shafi, Sambhaji, Ashok, Dushyant, Lalit, Kishor, Sumanta, Nilesh, Pradeep, Prakash, Harshali, Ravi, Sutar, Satish, Arvind, Selukar, Majid, Manish, Harbindu, Ankush, Kedar, Vinay, Ram, Ismail and all other friends at NCL as well as out of NCL, who helped me whenever it was needed; be it personal or research related. I owe my deepest gratitude and affection to my Father “ABBAJAN”. He inspired me to become a DOCTOR. No words would suffice to express my gratitude and love to AMMIJAN, my brother (Bhaijan) AEJAZ (The Right Man In The Right Place), adored sisters (Aapa) NAZNEEN and MUMTAJ, uncle Sd. ABDULLAH and brother-in-law KHALED and JAWED and all family members for their continuous showering of boundless affection on me and supporting me in whatever I chose or did. It is my parent’s prayer, constant struggle and relentless hard work to overcome the odds of life, which has inspired me to pursue life with a greater optimism. The moral values of my parents guided me throughout my life and I would always look up to them for strength no matter what I have to go through. This thesis is a result of the extraordinary wills, efforts and sacrifices of my parents. My successes are dedicated to them now and always. The love and support from my wife SADIYA who walked along with me, sharing every ups and downs is unparalleled and I am highly indebted to her for the sacrifice, help and encouragement for the healthy and inspiring environment. I thank my son SHAYAN (GOLU) for making my life more beautiful than it was. Finally, my acknowledgement would not be completed without thanking Almighty ALLAH, for giving me the strength and the determination to overcome the hardship faced in my life. Suleman R. Maujan CONTENTS Page No. * General remarks i * Abbreviations ii * Abstract iv Chapter 1: Synthesis of fluconazole analogues containing substituted thieno[2,3-d]pyrimidin-4(3H)-one and their bioevaluation Section I: Synthesis of fluconazole analogues containing substituted thieno[2,3-d]pyrimidin-4(3H)-one 1.1.1 Abstract 3 1.1.2 Introduction 3 1.1.3 Review of literature 4 1.1.4 Present work 26 1.1.4.1 Objective 26 1.1.4.2 Results and discussion 27 1.1.5 Conclusion 48 1.1.6 Experimental section 49 1.1.7 Selected spectra 115 1.1.8 References 135 Section II: Bioevaluation of fluconazole analogues containing substituted thieno[2,3-d]pyrimidin-4(3H)-one 1.2.1 Introduction 140 1.2.2 Present work 140 1.2.3 Results and discussion 140 1.2.4 Conclusion 149 1.2.5 References 150 Chapter 2: Synthesis of dimeric fluconazole analogues containing substituted thieno[2,3-d]pyrimidin-4(3H)-one and their bioevaluation 2.1 Abstract 152 2.2 Introduction 152 2.3 Review of literature 153 2.4 Present work 164 2.4.1 Objective 164 2.4.2 Results and discussion 165 2.5 Conclusion 176 2.6 Experimental section 177 2.7 Selected spectra 193 2.8 References 200 Chapter 3: Synthesis of fluconazole analogues containing 2H-1,4-benzothiazin- 3(4H)-ones or 2H-1,4-benzoxazin-3(4H)-ones and one-step preparation of α-chlorostyrenes Section I: Synthesis of fluconazole analogues containing 2H-1,4-benzothiazin- 3(4H)-ones or 2H-1,4-benzoxazin-3(4H)-ones 3.1.1 Abstract 204 3.1.2 Introduction 204 3.1.3 Review of literature 205 3.1.4 Present work 214 3.1.4.1 Objective 214 3.1.4.2 Results and discussion 215 3.1.5 Conclusion 224 3.1.6 Experimental section 225 3.1.7 Selected spectra 238 3.1.8 References 245 Section II: One-step preparation of α-chlorostyrenes 3.2.1 Abstract 249 3.2.2 Introduction 249 3.2.3 Review of literature 250 3.2.4 Present work 256 3.2.5 Conclusion 261 3.2.6 Experimental section 262 3.2.7 Selected spectra 271 3.2.8 References 279 List of publications 282 GENERAL REMARKS 1H NMR spectra were recorded on Bruker AC–200 MHz, Bruker AC–400 MHz and DRX–500 MHz spectrometer using tetramethylsilane (TMS) as an internal standard. Chemical shifts have been expressed in ppm units downfield from TMS. 13C NMR spectra were recorded on Bruker AC–200, Bruker AC–400 and DRX–500 instruments operating at 50 MHz, 100 MHz and 125 MHz respectively. EI Mass spectra were recorded on Finngan MAT–1020 spectrometer at 70 eV using a direct inlet system and applied Biosystems API QSTAR Pulsar Mass Spectrometer (Electrospray ionization, direct infusion method, solvents used were acetonitrile/methanol).
Recommended publications
  • Topical and Systemic Antifungal Therapy for Chronic Rhinosinusitis (Protocol)
    CORE Metadata, citation and similar papers at core.ac.uk Provided by University of East Anglia digital repository Cochrane Database of Systematic Reviews Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) Head K, Sacks PL, Chong LY, Hopkins C, Philpott C Head K, Sacks PL, Chong LY, Hopkins C, Philpott C. Topical and systemic antifungal therapy for chronic rhinosinusitis. Cochrane Database of Systematic Reviews 2016, Issue 11. Art. No.: CD012453. DOI: 10.1002/14651858.CD012453. www.cochranelibrary.com Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. TABLE OF CONTENTS HEADER....................................... 1 ABSTRACT ...................................... 1 BACKGROUND .................................... 1 OBJECTIVES ..................................... 3 METHODS ...................................... 3 ACKNOWLEDGEMENTS . 8 REFERENCES ..................................... 9 APPENDICES ..................................... 10 CONTRIBUTIONSOFAUTHORS . 25 DECLARATIONSOFINTEREST . 26 SOURCESOFSUPPORT . 26 NOTES........................................ 26 Topical and systemic antifungal therapy for chronic rhinosinusitis (Protocol) i Copyright © 2016 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. [Intervention Protocol] Topical and systemic antifungal therapy for chronic rhinosinusitis Karen Head1, Peta-Lee Sacks2, Lee Yee Chong1, Claire Hopkins3, Carl Philpott4 1UK Cochrane Centre,
    [Show full text]
  • Certain Pharmaceuticals and Intermediate Chemicals: Identification of Applicable 6-Digit HS Subheadings for Products Covered By
    Second Interim Report to the Public on CERTAIN PHARMACEUTICALS AND INTERMEDIATE CHEMICALS: IDENTIFI­ CATION OF APPLICABLE 6-DIGIT HS SUBHEADINGS. .· FOR PRODUCTS ·coVERED BY THE PROPOSED URUGUAY ROUND PHARMACEUTICAL A,GREEMENT Investigation No. 332-322 USITC PUBLICATION 2500 APRIL 1992 ,f~· United States International Trade Commission . ·J, Washington, DC 20436 . ·-~}~~:; . _:, -~;<$f ·!•;. UNITED STATES INTERNATIONAL TRADE COMMISSION COMMISSIONERS Don E. Newquist, Chairman Anne E. Brunsdale, Vice Chairman David B. Rohr Carol T. Crawford Janet A. Nuzum Peter S. Watson Office of Operations Charles W. Ervin, Director Office of Industries Rohen A. Rogowsky, Director This report was prepared principally by Eli?.abcth R. Ncsbiu Project Leader Aimison Jonnard Edward Matusik David Michels James Raftery Office of Industries David Beck Office of Tariff Affairs and Trade Agreements With assistance from Paul Daniels James Gill Office ofInformation Resources Management Under the direction of John J. Gersic, Chief Energy & Chemicals Division and Edmund D. Cappuccilli, Chief Energy, Petroleum, Benzenoid Chemicals, and Rubber and Plastics Branch · Energy & Chemicals Division Additional assistance provided by Brenda Carroll and Keilh Hipp With special assistance from U.S. Customs Service Address all communications to Kenneth R. Mason, Secreta·ry to the Commission United States International Trade Commission Washington, DC 20436 PREFACE This report is the second of two interim reports to the public pertaining to Commission investigation No. 332-322, entitled Certain Pharmaceuticals and Intermediate Chemicals; Identification of Applicable 6-Digit HS Subheadings for Products Covered by the Proposed Uruguay Round Pharmaceutical Agreement. The investigation was instituted following receipt of a letter from the United States Trade Representative (USTR) on January 27, 1992, requesting that the Commission conduct an investigation under section 332(g) of the Tariff Act of 1930 (see appendix A for a copy of the USTR' s request)·.
    [Show full text]
  • Discovery of New Antimicrobial Agents Using Combinatorial Chemistry
    Wright State University CORE Scholar Browse all Theses and Dissertations Theses and Dissertations 2007 Discovery of New Antimicrobial Agents using Combinatorial Chemistry William I. Northern Wright State University Follow this and additional works at: https://corescholar.libraries.wright.edu/etd_all Part of the Immunology and Infectious Disease Commons, and the Microbiology Commons Repository Citation Northern, William I., "Discovery of New Antimicrobial Agents using Combinatorial Chemistry" (2007). Browse all Theses and Dissertations. 206. https://corescholar.libraries.wright.edu/etd_all/206 This Thesis is brought to you for free and open access by the Theses and Dissertations at CORE Scholar. It has been accepted for inclusion in Browse all Theses and Dissertations by an authorized administrator of CORE Scholar. For more information, please contact [email protected]. DISCOVERY OF NEW ANTIMICROBIAL AGENTS USING COMBINATORIAL CHEMISTRY A thesis submitted in partial fulfillment Of the requirements for the degree of Master of Science By WILLIAM ISAAC NORTHERN B.S., University of Cincinnati, 1982 2007 Wright State University WRIGHT STATE UNIVERSITY SCHOOL OF GRADUATE STUDIES October 29, 2007 I HEREBY RECOMMEND THAT THE THESIS PREPAIRED UNDER MY SUPERVISION BY William Isaac Northern ENTITLED Discovery of New Antimicrobial Agents Using Combinatorial Chemistry BE ACCEPTED IN PARTIAL FULFULLMENT OF THE REQUIREMENTS FOR THE DEGREE OF Master of Science ______________________________ Nancy Bigley, Ph.D. Thesis Director ______________________________ Barbara Hull, Ph.D. Department Chair Committee on Final Examination ______________________________ Nancy Bigley. Ph.D. ______________________________ Barbara Hull, Ph.D. ______________________________ Daniel Ketcha, Ph.D. ______________________________ Gerald Alter, Ph.D. ______________________________ Joseph F. Thomas, Jr., Ph.D. Dean, School of Graduate Studies ABSTRACT Northern, William Isaac.
    [Show full text]
  • Fungi P1: OTA/XYZ P2: ABC JWST082-FM JWST082-Kavanagh July 11, 2011 19:19 Printer Name: Yet to Come
    P1: OTA/XYZ P2: ABC JWST082-FM JWST082-Kavanagh July 11, 2011 19:19 Printer Name: Yet to Come Fungi P1: OTA/XYZ P2: ABC JWST082-FM JWST082-Kavanagh July 11, 2011 19:19 Printer Name: Yet to Come Fungi Biology and Applications Second Edition Editor Kevin Kavanagh Department of Biology National University of Ireland Maynooth Maynooth County Kildare Ireland A John Wiley & Sons, Ltd., Publication P1: OTA/XYZ P2: ABC JWST082-FM JWST082-Kavanagh July 11, 2011 19:19 Printer Name: Yet to Come This edition first published 2011 © 2011 by John Wiley & Sons, Ltd. Wiley-Blackwell is an imprint of John Wiley & Sons, formed by the merger of Wiley’s global Scientific, Technical and Medical business with Blackwell Publishing. Registered Office: John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial Offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/ wiley-blackwell. The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
    [Show full text]
  • Unexpected Cell Wall Alteration-Mediated Bactericidal
    Unexpected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium Christophe Isnard, Sara B. Hernández, François Guérin, Fanny Joalland, Didier Goux, François Gravey, Michel Auzou, David P. Enot, Pierrick Meignen, Jean-Christophe Giard, et al. To cite this version: Christophe Isnard, Sara B. Hernández, François Guérin, Fanny Joalland, Didier Goux, et al.. Un- expected cell wall alteration-mediated bactericidal activity of the antifungal caspofungin against vancomycin-resistant Enterococcus faecium. Antimicrobial Agents and Chemotherapy, American So- ciety for Microbiology, 2020, 64 (10), 10.1128/AAC.01261-20. hal-02930693 HAL Id: hal-02930693 https://hal.archives-ouvertes.fr/hal-02930693 Submitted on 15 Sep 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. 1 Unexpected cell wall alteration-mediated bactericidal activity of the 2 antifungal caspofungin against vancomycin-resistant Enterococcus faecium 3 4 Running title: In vitro activity of caspofungin against E. faecium
    [Show full text]
  • Effectiveness of 7.5 Percent Povidone Iodine in Comparison to 1 Percent Clotrimazole in the Treatment of Otomycosis
    EFFECTIVENESS OF 7.5 PERCENT POVIDONE IODINE IN COMPARISON TO 1 PERCENT CLOTRIMAZOLE IN THE TREATMENT OF OTOMYCOSIS A DISSERTATION SUBMITTED IN PARTIAL FULFILLMENT OF M.S BRANCH –IV (OTORHINOLARYNGOLOGY EXAMINATION OF THE DR.MGR. MEDICAL UNIVERSITY TO BE HELD IN APRIL 2012 ACKNOWLEDGEMENTS I wish to express my deep gratitude to Dr Anand Job, Professor and Head of Unit 1, Department of Otorhinolaryngology, Speech and Hearing, Christian Medical College and Hospital, Vellore for his able guidance and encouragement in conducting this study and preparing this dissertation. I wish to express my deep gratitude to Dr Achamma Balraj, Head of the Department of Otorhinolaryngology, Speech and Hearing, Christian Medical College and Hospital, Vellore for her able guidance and encouragement in conducting this study and preparing this dissertation. I would like to thank Dr Rita Ruby Albert, Dr Regi Thomas, and Dr Rajan Sundaresan from the Department of Otorhinolaryngology for being my co-investigators in this study. I am extremely thankful to Dr Shalini Anandan, Assistant professor, Department of Microbiology for her guidance in this study. I am thankful to Dr Selvaraj from the Department of Biostatistics for his able guidance in the statistical analysis of this study. I would like to thank the Fluid Research Committee, CMC Hospital for granting me financial assistance for conducting this study. Last but not the least; I would like to thank all my patients who participated with me in this study for their kind co-operation. CERTIFICATE This is to certify that the dissertation entitled “Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole in the treatment of otomycosis” is a bonafide original work of Dr Ajay Philip, submitted in partial fulfillment of the rules and regulations for the MS Branch IV, Otorhinolaryngology examination of The Tamil Nadu Dr.
    [Show full text]
  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
    20558 Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DEPARMENT OF THE TREASURY Services, U.S. Customs Service, 1301 TABLE 1.ÐPHARMACEUTICAL APPEN- Constitution Avenue NW, Washington, DIX TO THE HTSUSÐContinued Customs Service D.C. 20229 at (202) 927±1060. CAS No. Pharmaceutical [T.D. 95±33] Dated: April 14, 1995. 52±78±8 ..................... NORETHANDROLONE. A. W. Tennant, 52±86±8 ..................... HALOPERIDOL. Pharmaceutical Tables 1 and 3 of the Director, Office of Laboratories and Scientific 52±88±0 ..................... ATROPINE METHONITRATE. HTSUS 52±90±4 ..................... CYSTEINE. Services. 53±03±2 ..................... PREDNISONE. 53±06±5 ..................... CORTISONE. AGENCY: Customs Service, Department TABLE 1.ÐPHARMACEUTICAL 53±10±1 ..................... HYDROXYDIONE SODIUM SUCCI- of the Treasury. NATE. APPENDIX TO THE HTSUS 53±16±7 ..................... ESTRONE. ACTION: Listing of the products found in 53±18±9 ..................... BIETASERPINE. Table 1 and Table 3 of the CAS No. Pharmaceutical 53±19±0 ..................... MITOTANE. 53±31±6 ..................... MEDIBAZINE. Pharmaceutical Appendix to the N/A ............................. ACTAGARDIN. 53±33±8 ..................... PARAMETHASONE. Harmonized Tariff Schedule of the N/A ............................. ARDACIN. 53±34±9 ..................... FLUPREDNISOLONE. N/A ............................. BICIROMAB. 53±39±4 ..................... OXANDROLONE. United States of America in Chemical N/A ............................. CELUCLORAL. 53±43±0
    [Show full text]
  • View U.S. Patent Application Publication No. US-2020-0056988
    1111111111111111 IIIIII IIIII 1111111111 11111 11111 111111111111111 IIIII IIIII IIIIII IIII 11111111 US 20200056988Al c19) United States c12) Patent Application Publication c10) Pub. No.: US 2020/0056988 Al Butz et al. (43) Pub. Date: Feb. 20, 2020 (54) METHOD OF DETERMINING THE Publication Classification EFFICACY OF ANTIMICROBIALS (51) Int. Cl. GOIN 2113504 (2006.01) (71) Applicant: Wisconsin Alumni Research GOIN 33/497 (2006.01) Foundation, Madison, WI (US) (52) U.S. Cl. CPC ....... GOIN 2113504 (2013.01); GOIN 33/497 (72) Inventors: Daniel Elmer Butz, Madison, WI (US); (2013.01) Ann P. O'Rourke, Madison, WI (US); Mark E. Cook, Madison, WI (US) (57) ABSTRACT A method of determining efficacy of an antimicrobial treat­ ment in a subject includes calculating a breath delta value (21) Appl. No.: 16/540,627 (BDV) for each of at least six breath samples acquired from the subject over a 24 hour period starting from when the subject has been administered the antimicrobial treatment, (22) Filed: Aug. 14, 2019 calculating a mean standard deviation of BDV (SD BDV) across the six or more breath samples; and determining that the antimicrobial treatment is effective when the SD BDV is Related U.S. Application Data less than or equal to 0.46, or determining that the antimi­ crobial treatment is ineffective when the SD BDV is greater (60) Provisional application No. 62/764,874, filed on Aug. than 0.46. Also included are methods of treating a subject in 16, 2018. need of antimicrobial treatment. r Ass~sse~.f~;·el;~!~i!lt;·~n~~·~1)···· i ,, --~----·--··--···············r··············•······-·······•_.•.•.•.•_.•.•.•.•_J________ ___.........,., ; Excluded (no:299) r- ➔@!~;;;:~=:· ~··· Consented for partidpatfon {ir=32) Wi!hdrawn: • Exdusionary Criteria (ri=3) • Withdrawn by lnve.stigator(n"'2) Analyzed {n:=27) , Excluded from analysis {inadequate breath samples} {n=7} • 20 Subjects Anaiyze<l: o 13 Male; 7 Femi.lie o 76.2% Caucasian: VU% African American: 9.5% Other o 19% 18-35 yfo; 33_3% 36-54 yfo; 33.3% 55-73 yfo: i4.3 74+ yto Patent Application Publication Feb.
    [Show full text]
  • Stembook 2018.Pdf
    The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances FORMER DOCUMENT NUMBER: WHO/PHARM S/NOM 15 WHO/EMP/RHT/TSN/2018.1 © World Health Organization 2018 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances. Geneva: World Health Organization; 2018 (WHO/EMP/RHT/TSN/2018.1). Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data.
    [Show full text]
  • A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
    A abacavir abacavirum abakaviiri abagovomab abagovomabum abagovomabi abamectin abamectinum abamektiini abametapir abametapirum abametapiiri abanoquil abanoquilum abanokiili abaperidone abaperidonum abaperidoni abarelix abarelixum abareliksi abatacept abataceptum abatasepti abciximab abciximabum absiksimabi abecarnil abecarnilum abekarniili abediterol abediterolum abediteroli abetimus abetimusum abetimuusi abexinostat abexinostatum abeksinostaatti abicipar pegol abiciparum pegolum abisipaaripegoli abiraterone abirateronum abirateroni abitesartan abitesartanum abitesartaani ablukast ablukastum ablukasti abrilumab abrilumabum abrilumabi abrineurin abrineurinum abrineuriini abunidazol abunidazolum abunidatsoli acadesine acadesinum akadesiini acamprosate acamprosatum akamprosaatti acarbose acarbosum akarboosi acebrochol acebrocholum asebrokoli aceburic acid acidum aceburicum asebuurihappo acebutolol acebutololum asebutololi acecainide acecainidum asekainidi acecarbromal acecarbromalum asekarbromaali aceclidine aceclidinum aseklidiini aceclofenac aceclofenacum aseklofenaakki acedapsone acedapsonum asedapsoni acediasulfone sodium acediasulfonum natricum asediasulfoninatrium acefluranol acefluranolum asefluranoli acefurtiamine acefurtiaminum asefurtiamiini acefylline clofibrol acefyllinum clofibrolum asefylliiniklofibroli acefylline piperazine acefyllinum piperazinum asefylliinipiperatsiini aceglatone aceglatonum aseglatoni aceglutamide aceglutamidum aseglutamidi acemannan acemannanum asemannaani acemetacin acemetacinum asemetasiini aceneuramic
    [Show full text]
  • Candida Albicans from Vaginal Ulcer and Separation of Enolase on SDS-PAGE
    Vol. 2, No. 1 International Journal of Biology Culture and Identification of Candida Albicans from Vaginal Ulcer and Separation of Enolase on SDS-PAGE P. Saravana Bhavan (Corresponding author) Department of Zoology, Bharathiar University Coimbatore 641046, Tamilnadu, India Tel: 91-422-242-2222 Ext. 495 E-mail: [email protected] R. Rajkumar PRIDE, Periyar University Salem 636011, Tamilnadu, India E-mail: [email protected] S. Radhakrishnan Department of Zoology, Bharathiar University Coimbatore 641046, Tamilnadu, India E-mail: [email protected] C. Seenivasan Department of Zoology, Bharathiar University Coimbatore 641046, Tamilnadu, India E-mail: [email protected] S. Kannan Department of Zoology, Bharathiar University Coimbatore 641046, Tamilnadu, India E-mail: [email protected] Abstract Candida albicans were isolated from patients with clinical symptoms of vaginal ulcer. Culture test for vaginal swab and scrapings were conducted on Sabouraud’s dextrose broth and Sabouraud’s dextrose agar plate respectively. Hichrome candida agar culture was used for differential identification of Candida. Smears from vaginal scrapings were prepared for gram staining. The suspected strain of Candida was inoculated on corn meal agar medium for chlamydospore formation. The suspected strain of Candida was inoculated in human serum for germ tube formation. Carbohydrate assimilation and fermentation tests were also conducted. The selected Candida colony was inoculated in YEPD medium for subculture and the cultured organism was harvested. The organisms were homogenized, centrifuged and the supernatant was filtered. The filtrate was extracted in chloroform. The extract was centrifuged and the aqueous phase was dialyzed. The dialyzed crude enolase was subjected to SDS-PAGE. The Sabouraud’s dextrose broth inoculated with vaginal swab showed turbid growth.
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 7,605,138 B2 Krieg (45) Date of Patent: Oct
    USOO7605138B2 (12) United States Patent (10) Patent No.: US 7,605,138 B2 Krieg (45) Date of Patent: Oct. 20, 2009 (54) NUCLEICACID COMPOSITIONS FOR 6,589,940 B1 7/2003 Raz et al. STMULATING IMMUNE RESPONSES 6,610,308 B1 8, 2003 Haensler 6,610,661 B1 8, 2003 Carson et al. (75) Inventor: Arthur M. Krieg, Wellesley, MA (US) 6,653,292 B1 1 1/2003 Krieg et al. 6,727,230 B1 4/2004 Hutcherson et al. (73) Assignee: Coley Pharmaceutical Group, Inc., 6,749,856 B1 6/2004 Berzofsky et al. New York, NY (US) 6.821,957 B2 11/2004 Krieg et al. 6,835,395 B1 12/2004 Semple et al. (*) Notice: Subject to any disclaimer, the term of this 6,852,705 B2 2/2005 Audonnet et al. patent is extended or adjusted under 35 6,943,240 B2 9, 2005 Bauer et al. U.S.C. 154(b) by 732 days. 6,949,520 B1 9, 2005 Hartmann et al. 7,001,890 B1 2/2006 Wagner et al. (21) Appl. No.: 10/613,524 7,223,741 B2 5/2007 Krieg 7,271,156 B2 9/2007 Krieg et al. (22) Filed: Jul. 3, 2003 7.303,881 B2 12/2007 Huang et al. 7,354,711 B2 4/2008 Macfarlane (65) Prior Publication Data 7,354,909 B2 4/2008 Klinman et al. 7,402,572 B2 7/2008 Krieg et al. US 2004/O19868O A1 Oct. 7, 2004 7,410,975 B2 8/2008 Lipford et al. 2001/0044416 A1 11/2001 McCluskie et al.
    [Show full text]